Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women.

Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. J Pregnancy (2014) 0.92

Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes. Am J Perinatol (2012) 0.83

Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand. Drug Alcohol Depend (2012) 0.82

Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation. Obstet Gynecol (2017) 0.81

Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes. Addiction (2012) 0.78

A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report. J Dual Diagn (2015) 0.76

Substance Use in the Perinatal Period. Curr Psychiatry Rep (2015) 0.76

Should pregnant women with substance use disorders be managed differently? Neuropsychiatry (London) (2012) 0.76

Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment. Curr Addict Rep (2017) 0.75

Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations. Clin Obstet Gynecol (2015) 0.75

Family Risk Factors Among Women With Addiction-Related Problems: An Integrative Review. Int J High Risk Behav Addict (2016) 0.75

A longitudinal study on substance use and related problems in women in opioid maintenance treatment from pregnancy to four years after giving birth. Subst Abuse (2014) 0.75

Substance use during pregnancy. F1000Res (2016) 0.75

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry (1994) 48.75

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry (1992) 21.60

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA (1990) 17.70

Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry (2004) 6.80

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA (2006) 6.48

Prevalence of depression during pregnancy: systematic review. Obstet Gynecol (2004) 5.42

A controlled trial of buprenorphine treatment for opioid dependence. JAMA (1992) 3.55

Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry (2007) 3.40

Trauma, PTSD, and substance use disorders: findings from the Australian National Survey of Mental Health and Well-Being. Am J Psychiatry (2006) 2.50

Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry (2007) 2.47

Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev (2000) 2.35

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend (2005) 2.26

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry (1996) 2.23

Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction (2006) 2.04

Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend (2002) 1.97

A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry (2007) 1.80

Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat (2008) 1.77

Race/ethnic differences in the prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med (2006) 1.71

Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend (2004) 1.60

Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend (2008) 1.57

Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat (2006) 1.22

Borderline personality disorder, mother-infant interaction and parenting perceptions: preliminary findings. Aust N Z J Psychiatry (2007) 1.13

The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf (2005) 1.07

Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan. Psychiatry Clin Neurosci (2007) 1.03

Reliability and validity of the Kessler 10 and Patient Health Questionnaire among injecting drug users. Aust N Z J Psychiatry (2007) 1.01

Borderline personality disorder and substance abuse: consequences of comorbidity. Can J Psychiatry (1995) 0.97

CONTRIBUTIONS OF THE MOTHER-INFANT RELATIONSHIP TO DISSOCIATIVE, BORDERLINE, AND CONDUCT SYMPTOMS IN YOUNG ADULTHOOD. Infant Ment Health J (2008) 0.93

The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients. Am J Drug Alcohol Abuse (2009) 0.93

Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict (2009) 0.92

Illicit drug use among women with children in the United States: 2002-2003. Ann Epidemiol (2009) 0.90

Methadone use during pregnancy. NIDA Res Monogr (1995) 0.82

A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction (2006) 8.57

Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med (2010) 3.84

Delay discounting predicts postpartum relapse to cigarette smoking among pregnant women. Exp Clin Psychopharmacol (2007) 2.77

Clinical implications of reinforcement as a determinant of substance use disorders. Annu Rev Psychol (2004) 2.74

Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study. J Addict Med (2015) 2.38

A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. JAMA Psychiatry (2013) 2.29

A pilot study on voucher-based incentives to promote abstinence from cigarette smoking during pregnancy and postpartum. Nicotine Tob Res (2004) 2.23

Community reinforcement therapy for cocaine-dependent outpatients. Arch Gen Psychiatry (2003) 2.20

The occurrence of cannabis use disorders and other cannabis-related problems among first-year college students. Addict Behav (2007) 2.11

Distance traveled to outpatient drug treatment and client retention. J Subst Abuse Treat (2003) 1.86

Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. Addiction (2007) 1.83

Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat (2008) 1.77

Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction (2010) 1.71

Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol (2003) 1.70

Nonmedical Use of Prescription Stimulants and Analgesics: Associations with Social and Academic Behaviors among College Students. J Drug Issues (2008) 1.63

Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction (2005) 1.57

A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3. Hepatology (2008) 1.56

Maternal smoking and its association with birth weight. Obstet Gynecol (2005) 1.55

Prevalence and predictors of persistent suicide ideation, plans, and attempts during college. J Affect Disord (2010) 1.54

Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction (2008) 1.51

Sociodemographic correlates of energy drink consumption with and without alcohol: results of a community survey. Addict Behav (2010) 1.50

Biochemical verification of smoking status in pregnant and recently postpartum women. Exp Clin Psychopharmacol (2007) 1.45

Firesetting in adolescence and being aggressive, shy, and rejected by peers: new epidemiologic evidence from a national sample survey. J Am Acad Psychiatry Law (2003) 1.44

Financial incentives for smoking cessation among pregnant and newly postpartum women. Prev Med (2011) 1.44

Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Fetal Neonatal Med (2012) 1.43

Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend (2003) 1.36

Educational disadvantage and cigarette smoking during pregnancy. Drug Alcohol Depend (2009) 1.32

Nonmedical use of prescription stimulants during college: four-year trends in exposure opportunity, use, motives, and sources. J Am Coll Health (2012) 1.32

Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend (2006) 1.31

Sharing and selling of prescription medications in a college student sample. J Clin Psychiatry (2010) 1.31

Maintaining Superior Follow-Up Rates in a Longitudinal Study: Experiences from the College Life Study. Int J Mult Res Approaches (2012) 1.27

Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend (2004) 1.26

Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction (2012) 1.25

Predictors of postpartum relapse to smoking. Drug Alcohol Depend (2007) 1.25

Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol (2013) 1.25

College students rarely seek help despite serious substance use problems. J Subst Abuse Treat (2009) 1.24

Smoking status in the initial weeks of quitting as a predictor of smoking-cessation outcomes in pregnant women. Drug Alcohol Depend (2006) 1.22

Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat (2006) 1.22

Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol (2010) 1.22

Marijuana exposure opportunity and initiation during college: parent and peer influences. Prev Sci (2012) 1.20

Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. Pediatrics (2008) 1.18

Disruption of frontocerebellar circuitry and function in alcoholism. Alcohol Clin Exp Res (2003) 1.18

Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study. J Appl Behav Anal (2008) 1.17

Evidence for significant polydrug use among ecstasy-using college students. J Am Coll Health (2006) 1.17

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes. Subst Abuse (2013) 1.16

Longitudinal brain metabolic characterization of chronic alcoholics with proton magnetic resonance spectroscopy. Alcohol Clin Exp Res (2002) 1.16

Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J (2009) 1.16

Effect of roasting on the formation of chlorogenic acid lactones in coffee. J Agric Food Chem (2005) 1.15

Response to Wouldes and Woodward: maternal methadone dose during pregnancy and infant clinical outcome. Neurotoxicol Teratol (2013) 1.15

Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Alcohol Alcohol (2002) 1.14

Delay discounting is associated with treatment response among cocaine-dependent outpatients. Exp Clin Psychopharmacol (2011) 1.14

The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review. Drug Alcohol Depend (2011) 1.14

Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat (2010) 1.14

Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study. Addict Behav (2008) 1.13

Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned. Addiction (2012) 1.13

An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students. Subst Use Misuse (2005) 1.12

Sertraline treatment of co-occurring alcohol dependence and major depression. J Clin Psychopharmacol (2006) 1.12

Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction (2003) 1.11

Effects of smoking cessation with voucher-based contingency management on birth outcomes. Addiction (2010) 1.10

Cocaine use in Europe - a multi-centre study. Methodology and prevalence estimates. Eur Addict Res (2004) 1.10

Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study. Ther Drug Monit (2009) 1.10

Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. Am J Addict (2013) 1.10

Effects of cigarette smoking cessation on breastfeeding duration. Nicotine Tob Res (2010) 1.08

A partner's drug-using status impacts women's drug treatment outcome. Drug Alcohol Depend (2003) 1.08